Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B1c0dd221774eae04ec005409d34d2c49> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B1c0dd221774eae04ec005409d34d2c49 NCIT_P378 "NCI" @default.
- B1c0dd221774eae04ec005409d34d2c49 type Axiom @default.
- B1c0dd221774eae04ec005409d34d2c49 annotatedProperty IAO_0000115 @default.
- B1c0dd221774eae04ec005409d34d2c49 annotatedSource NCIT_C47563 @default.
- B1c0dd221774eae04ec005409d34d2c49 annotatedTarget "A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)" @default.